D&L Industries, Inc.
D&L Industries, Inc. (DALQF) Financial Performance & Income Statement Overview
Analyze D&L Industries, Inc. (DALQF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
D&L Industries, Inc. (DALQF) Income Statement & Financial Overview
Analyze D&L Industries, Inc.’s DALQF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.19B | $10.51B | $10.14B | $8.83B |
| Cost of Revenue | $9.69B | $8.82B | $8.59B | $7.32B |
| Gross Profit | $1.50B | $1.69B | $1.56B | $1.51B |
| Gross Profit Ratio | $0.13 | $0.16 | $0.15 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$67.62M | $669.53M | $585.52M | $540.27M |
| Operating Expenses | $765.63M | $750.01M | $505.002M | $540.27M |
| Total Costs & Expenses | $10.46B | $9.57B | $9.09B | $7.86B |
| Interest Income | -$6.54M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $318.20M | $225.17M | $204.20M | $223.10M |
| Depreciation & Amortization | $416.27M | $309.52M | $194.37M | $240.95M |
| EBITDA | $1.15B | $1.25B | $1.25B | $1.16B |
| EBITDA Ratio | $0.10 | $0.12 | $0.12 | $0.13 |
| Operating Income | $736.01M | $938.68M | $1.05B | $967.97M |
| Operating Income Ratio | $0.07 | $0.09 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | -$318.20M | -$225.17M | -$204.20M | -$223.10M |
| Income Before Tax | $417.82M | $713.51M | $847.17M | $787.74M |
| Income Before Tax Ratio | $0.04 | $0.07 | $0.08 | $0.09 |
| Income Tax Expense | -$114.78M | $220.32M | $148.72M | $169.84M |
| Net Income | $532.60M | $493.19M | $698.45M | $617.90M |
| Net Income Ratio | $0.05 | $0.05 | $0.07 | $0.07 |
| EPS | $0.07 | $0.00 | $0.10 | $0.09 |
| Diluted EPS | $0.07 | $0.00 | $0.10 | $0.09 |
| Weighted Avg Shares Outstanding | $7.31B | $0.00 | $7.31B | $7.14B |
| Weighted Avg Shares Outstanding (Diluted) | $7.31B | $0.00 | $7.31B | $7.14B |
Over the past four quarters, D&L Industries, Inc. demonstrated steady revenue growth, increasing from $8.83B in Q1 2024 to $11.19B in Q4 2024. Operating income reached $736.01M in Q4 2024, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.15B, reflecting operational efficiency. Net income rose to $532.60M, with EPS at $0.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan